Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S20 pseudogene 24 (RPS20P24) is a processed pseudogene in the human genome, related to the functional ribosomal protein S20 gene. Unlike its parent gene RPS20, which encodes a protein component of the small 40S ribosomal subunit essential for protein synthesis, RPS20P24 does not produce a functional protein and has no known biological or pharmacological roles. Pseudogenes are generally considered genomic remnants without direct cellular function, although rare exceptions exist where pseudogene transcripts may have regulatory roles. There are multiple RPS20 pseudogenes scattered throughout the genome, but RPS20P24 itself is not implicated in disease or targeted by drugs
Not applicable; no known mechanism, since pseudogenes do not produce functional proteins or have enzymatic or receptor activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S20 pseudogene 24 (RPS20P24).